Retatrutide

Weight loss

$460.00

Retratutide (also known as LY3437943) is an investigational multi-agonist peptide being developed for potential use in metabolic and weight-management therapies. It is not yet FDA-approved, but early research has generated interest because of its unique combination of hormonal actions.

How It Works (Mechanistically)

Retratutide is designed as a triple-agonist, meaning it activates three different receptors involved in appetite, metabolism, and energy balance:

  1. GLP-1 receptor agonist

    • Helps regulate appetite

    • Slows gastric emptying

    • Supports blood-sugar control

  2. GIP receptor agonist

    • Enhances insulin response after meals

    • May work synergistically with GLP-1 for appetite reduction

  3. Glucagon receptor agonist

    • Increases energy expenditure

    • Promotes fat-burning through increased metabolic activity

This combination aims to target multiple metabolic pathways at once, potentially offering stronger effects than single-target peptides.